Tamra Meyer

United States Food and Drug Administration

Poster(s):

• (B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET